Answers are grounded in this paper and cite their sources.
Contrary to common expectations, chronic NF-κB activation induced intestinal crypt apoptosis after TNF stimulation, resulting in severe mucosal erosion. RIPK1 kinase inhibitors selectively inhibited TNF destructive properties while preserving its survival and proliferative properties, which do not require RIPK1 kinase activity. RIPK1 kinase inhibition could be a potential treatment for IBD.
No takes yet. Share an insight, caveat, or question.
Wong et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: